X4 Pharmaceuticals
XFOR
XFOR
93 hedge funds and large institutions have $81.5M invested in X4 Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $123M → $81.5M (-$41M)
54% less call options, than puts
Call options by funds: $195K | Put options by funds: $426K
Holders
93
Holding in Top 10
–
Calls
$195K
Puts
$426K
Top Buyers
| 1 | +$1.26M | |
| 2 | +$830K | |
| 3 | +$801K | |
| 4 |
Morgan Stanley
New York
|
+$470K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$271K |
Top Sellers
| 1 | -$8.18M | |
| 2 | -$6.81M | |
| 3 | -$5.75M | |
| 4 |
Millennium Management
New York
|
-$1.64M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$466K |